Cargando…

Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis

15-F(2t)-Isoprostane, a reliable biomarker of oxidative stress, has been found elevated in exhaled breath condensate (EBC), a non-invasive technique for sampling of airway secretions, in patients with cystic fibrosis (CF). Azithromycin has antioxidant properties in experimental models of CF, but its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montuschi, Paolo, Lucidi, Vincenzina, Paris, Debora, Montemitro, Enza, Shohreh, Rugia, Mores, Nadia, Melck, Dominique, Santini, Giuseppe, Majo, Fabio, Motta, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015879/ https://www.ncbi.nlm.nih.gov/pubmed/29967580 http://dx.doi.org/10.3389/fphar.2018.00595

Ejemplares similares

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

Exploring Airway Diseases by NMR-Based Metabonomics: A Review of Application to Exhaled Breath Condensate
por: Sofia, Matteo, et al.
Publicado: (2011)

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects
por: Malerba, Mario, et al.
Publicado: (2018)

Environmental Microbial Contamination during Cystic Fibrosis Group-Based Psychotherapy
por: Rossitto, Martina, et al.
Publicado: (2021)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
por: Montuschi, Paolo, et al.
Publicado: (2018)

Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
por: Di Costanzo, Alfonso, et al.
Publicado: (2020)

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
por: Vernocchi, Pamela, et al.
Publicado: (2017)

Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype
por: Vernocchi, Pamela, et al.
Publicado: (2018)

Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study
por: Lucidi, Vincenzina, et al.
Publicado: (2009)

Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy
por: D'Apice, Maria Rosaria, et al.
Publicado: (2004)

Pharmacological treatment of chronic obstructive pulmonary disease
por: Montuschi, Paolo
Publicado: (2006)

Editorial: Insights in respiratory pharmacology: 2021
por: Montuschi, Paolo, et al.
Publicado: (2022)

A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease
por: Bacci, Giovanni, et al.
Publicado: (2017)

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study
por: Foppiani, Andrea, et al.
Publicado: (2023)

Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease
por: Bacci, Giovanni, et al.
Publicado: (2020)

NMR Profiling of Exhaled Breath Condensate Defines Different Metabolic Phenotypes of Non-Cystic Fibrosis Bronchiectasis
por: Paris, Debora, et al.
Publicado: (2020)

Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function
por: Paganin, Patrizia, et al.
Publicado: (2015)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
por: Medino, Paola, et al.
Publicado: (2022)

Proteomics and Metabolomics for Cystic Fibrosis Research
por: Liessi, Nara, et al.
Publicado: (2020)

IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
por: Iannitti, Rossana G., et al.
Publicado: (2016)

Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors
por: Iafusco, Fernanda, et al.
Publicado: (2021)

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
por: Moretti, Silvia, et al.
Publicado: (2017)

Lessons learned from metabolomics in cystic fibrosis
por: Muhlebach, Marianne S., et al.
Publicado: (2015)

Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate
por: Maniscalco, Mauro, et al.
Publicado: (2022)

Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort
por: Cornet, Matthieu, et al.
Publicado: (2022)

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
por: Bacci, Giovanni, et al.
Publicado: (2016)

Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response
por: Poerio, Noemi, et al.
Publicado: (2020)

Clinical expression of cystic fibrosis in a large cohort of Italian siblings
por: Terlizzi, Vito, et al.
Publicado: (2018)

Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
por: Bacci, Giovanni, et al.
Publicado: (2016)

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
por: Dolce, Daniela, et al.
Publicado: (2019)

Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis
por: Pinto, Madalena C, et al.
Publicado: (2021)

Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis
por: Sofia, Valentina Maria, et al.
Publicado: (2018)

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
por: Devereux, Graham, et al.
Publicado: (2020)

Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome
por: Quinn, Robert A, et al.
Publicado: (2016)

Cystic Fibrosis: Fighting Together Against Coronavirus Infection
por: Manti, Sara, et al.
Publicado: (2020)

Focus on gastroesophageal reflux disease in patients with cystic fibrosis
por: Bongiovanni, Annarita, et al.
Publicado: (2020)

299: Stress and mental health in cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample
por: Graziano, S., et al.
Publicado: (2021)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
por: Neerincx, Anne H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2bauencv50ivref1jjtup22iuk